irinotecan has been researched along with calcimycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kizaki, H; Oguro, M; Onishi, Y | 1 |
| Alnajim, J; Anantha, M; Bally, M; Ramsay, E; Waterhouse, D; Webb, M; Yan, H; Zastre, J | 1 |
| Anantha, M; Bally, M; Patankar, N; Ramsay, E; Waterhouse, D | 1 |
3 other study(ies) available for irinotecan and calcimycin
| Article | Year |
|---|---|
4-Piperidinopiperidine-resistant lymphoma cells were resistant to dexamethasone- and A23187-induced apoptosis.
Topics: Apoptosis; Calcimycin; Camptothecin; Dexamethasone; DNA Fragmentation; Drug Resistance; Humans; Irinotecan; Lymphoma; Piperidines; Tumor Cells, Cultured | 1998 |
A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calcimycin; Camptothecin; Chemistry, Pharmaceutical; Copper Sulfate; Female; Hydrogen-Ion Concentration; Irinotecan; Liposomes; Mice; Mice, Inbred BALB C | 2008 |
The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™.
Topics: Animals; Antineoplastic Agents; Calcimycin; Camptothecin; Cell Membrane Permeability; Chemistry, Pharmaceutical; Cholesterol; Chromatography, High Pressure Liquid; Copper; Female; Ionophores; Irinotecan; Liposomes; Mice; Mice, Inbred BALB C; Phosphatidylcholines | 2011 |